ROSEMARY TREVINO: Open Payments
NPI 1619490463 · WALLIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 28 payments from 16 companies in 2025. Trend: 2023 $929 · 2024 $690 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $111 |
| ABIOMED | 2 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $64 |
| Abbott Laboratories | 2 | $47 |
| Novo Nordisk Inc | 2 | $44 |
| Exact Sciences Corporation | 2 | $40 |
| Viatris Specialty LLC | 1 | $34 |
| Eisai Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: VRAYLAR, XIFAXAN, FREESTYLE LIBRE 3, Rybelsus, YUPELRI, Leqembi, Cologuard Collection Kit, JARDIANCE.
Industry payments across TX — which companies pay providers there.
